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Abstract Pharmacobehavioral studies in experimental
animals, and imaging studies in humans, indicate that
serotonergic transmission in the amygdala plays a key role
in emotional processing, especially for anxiety-related
stimuli. The lateral and basolateral amygdaloid nuclei
receive a dense serotonergic innervation in all species
studied to date. We investigated interrelations between
serotonergic afferents and neuropeptide Y (NPY)-produc-
ing neurons, which are a subpopulation of inhibitory
interneurons in the rat lateral and basolateral nuclei with
particularly strong anxiolytic properties. Dual light
microscopic immunolabeling showed numerous apposi-
tions of serotonergic afferents on NPY-immunoreactive
somata. Using electron microscopy, direct membrane
appositions and synaptic contacts between serotonin-
containing axon terminals and NPY-immunoreactive cel-
lular profiles were unequivocally established. Double in
situ hybridization documented that more than 50 %, and
about 30–40 % of NPY mRNA-producing neurons, co-
expressed inhibitory 5-HT1A and excitatory 5-HT2C
mRNA receptor subtype mRNA, respectively, in both
nuclei with no gender differences. Triple in situ hybrid-
ization showed that individual NPY mRNA-producing
interneurons co-express both 5-HT1A and 5-HT2C
mRNAs. Co-expression of NPY and 5-HT3 mRNA was not
observed. The results demonstrate that serotonergic affer-
ents provide substantial innervation of NPY-producing
neurons in the rat lateral and basolateral amygdaloid
nuclei. Studies of serotonin receptor subtype co-expression
indicate a differential impact of the serotonergic innerva-
tion on this small, but important, population of anxiolytic
interneurons, and provide the basis for future studies of the
circuitry underlying serotonergic modulation of emotional
stimulus processing in the amygdala.
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Introduction
The amygdala is a heterogeneous telencephalic nuclear
complex which plays a key role in the processing of
emotional, particularly innate anxiety- and fear-related
stimuli, including the mediation of adequate autonomous,
endocrine and behavioral reactions, and the formation of
emotional memories both in rodents and humans (Damsa
et al. 2009; LeDoux 2000; Roozendaal et al. 2009). Each
amygdaloid nucleus subserves certain functions in emotion
processing. Thus, the lateral nucleus (La) is the amygdala’s
‘‘gatekeeper’’, receiving input from different sensory sys-
tems. From there, information is, in part, further transferred
to the basolateral nucleus (BL), which additionally receives
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hippocampal input. From La and BL, projections to the
central nucleus (Ce) arise, which is the most important
output station of the amygdala to endocrine and autono-
mous centers in the hypothalamus and brainstem (Ehrlich
et al. 2009; LeDoux 2000, 2007; Pitkanen et al. 1997).
Morphological and functional studies of the last decade
have yielded strong evidence that it is activation of the
amygdala, in particular, which underlies enhanced anxiety
(LeDoux 2000; Roozendaal et al. 2009). In addition,
functional imaging studies in humans consistently show
pathological activity patterns of the amygdala during the
course of affective disorders (Etkin and Schatzberg 2011).
Findings in experimental animals indicate that increased
neuronal activity, particularly of the basolateral amygdala,
is correlated with increased anxiety-like behavior (Wang
et al. 2011). Amygdala hyperexcitability accompanied by
increased spine density of pyramidal neurons in these
nuclei after stress has been found in wild type and genet-
ically modified mouse models for anxiety-related neuro-
psychiatric disorders (Nietzer et al. 2011; Rosenkranz et al.
2010). Pyramidal cells constitute about 85 % of the neu-
ronal population of the cortex-like La and BL. Electro-
physiological studies indicate that their activity is tightly
controlled by local inhibitory interneurons (Rainnie et al.
1991; Washburn and Moises 1992), which are mostly
GABAergic and can be classified into different subpopu-
lations based on the additional expression of calcium-
binding proteins and/or neuropeptides (Muller et al. 2003,
2007a). Neuropeptide Y (NPY)-immunoreactive (ir) inter-
neurons, which are a subgroup of Calbindin (CB)- and
somatostatin (SOM)-ir interneurons (McDonald 1989,
Truitt et al. 2009) are thought to be involved in anxiolytic
actions in the La and BL of rodents and humans. Thus,
electrophysiology studies documented significant inhibi-
tory actions of NPY on La pyramidal cell activity (Sosulina
et al. 2008). Moreover, in rats, the number of NPY-ir
neurons in La and BL is correlated inversely with anxiety-
like behavior (Yilmazer-Hanke et al. 2002, 2004), and
lesion of NPY-ir neurons results in increased anxiety-like
behavior (Truitt et al. 2009). In humans, a 30 % decrease in
NPY mRNA expression due to a genetic polymorphism
within the human NPY promoter region is associated with
increased amygdala activity upon exposure to threat-
related facial expressions (Zhou et al. 2008).
In all species studied to date, the La and BL possess an
exceptionally dense serotonergic innervation arising mainly
from the dorsal raphe nucleus (DR) (Fallon and Ciofi 1992;
Smith and Porrino 2008). Serotonergic neurotransmission is
implicated in various functions in the central nervous sys-
tem, ranging from the regulation of food intake, body
temperature and biorhythms to influencing attention, moti-
vation and other cognition (Kriegebaum et al. 2010). One of
its most relevant functions, from a psychiatric and social
point of view, is its impact on emotional states like anxiety
and associated psychiatric diseases. Thus, altered activation
of the amygdala during the processing of emotional stimuli
is characteristically observed in human carriers of the low-
expressing variant of the serotonin transporter gene
(5-HTT), a common polymorphism which is associated with
anxiety-related traits and an increased risk to develop post-
traumatic disorder or depression following stress experi-
ence (Caspi et al. 2003; Grabe et al. 2005; Hariri et al. 2002;
Lesch et al. 1996). There is ample electrophysiological and
pharmacobehavioral evidence that alterations in serotoner-
gic neurotransmission or differential serotonin receptor
(5-HTR) activation in the amygdala impact anxiety-like
behavior in rodents (Holmes 2008; Lowry et al. 2005). The
serotonin receptors 1A (5-HT1A), 2C (5-HT2C) and 3
(5-HT3) are expressed in the La and BL (Clemett et al.
2000; Miquel et al. 2002; Pazos and Palacios 1985) and
seem to be crucially involved in the regulation of anxiety-
related neuronal circuitries. These findings render interac-
tions of the serotonergic system with amygdaloid circuits of
significant interest for emotion research, and numerous
pharmacobehavioral studies have been carried out to elu-
cidate effects of serotonergic agonist or antagonist appli-
cation into the amygdala, albeit with occasionally
controversial results (Barnes and Sharp 1999; Lowry et al.
2005; Menard and Treit 1999).
Interpretation of these results requires identification of
serotonergic target neurons and of their receptor comple-
ment. In previous electron microscopic studies, membrane
appositions and synaptic contacts of serotonergic afferents
were verified on dendritic spines and distal dendrites of
calcium/calmodulin-dependent protein kinase II (CaMKII)-
ir pyramidal cells and on parvalbumin (PV)-ir and vaso-
active intestinal polypeptide (VIP)-ir interneurons of the
basolateral amygdaloid nucleus (Muller et al. 2007b).
Moreover, 5-HTR expression has been documented in
different neuron types (Aznar et al. 2003; Liu et al. 2007;
Mascagni and McDonald 2007; Yuen et al. 2008). Light
microscopic analyses additionally indicated contacts
between serotonergic afferents and, for instance, CB- and
SOM-ir interneurons (Muller et al. 2007b). Although of
obvious interest, analyses of a possible serotonergic
innervation of NPY-producing interneurons have not been
carried out yet. Therefore, in the present study, we performed
dual immunolabeling on a light (LM) and electron micro-
scopic (EM) level and correlative in situ hybridization (ISH)
for 5-HTR mRNA expression to determine interrelations
between the serotonergic system and the unique and special
interneuron subpopulation of anxiolytic NPY-producing
neurons in the La and BL. Since central serotonin levels
differ between male and female rats (Rosecrans 1970) and
behavioral studies in rodents suggest that changes in 5-HTR
equipment differentially affect behavior of males and
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females (Bhatnagar et al. 2004), 5-HTR expression studies
were performed separately in male and female rats.
Experimental procedures
Tissue preparation for LM, EM and ISH
Brains of 3-month-old male and female Wistar rats
(Charles River, Sulzfeld, Germany or Philadelphia, PA,
USA) were used for all experiments. Animal experiments
were carried out according to the German Law for the
Protection of Animals or were approved by the Institutional
Animal Care and Use Committee (IACUC) of Thomas
Jefferson University and were conducted in accordance
with the NIH Guide for the care and use of laboratory
animals. Only the minimal number of animals necessary to
produce reliable scientific data was used, and all efforts
were made to minimize animal suffering. For tissue prep-
aration for LM immunohistochemical studies, anesthetized
rats were briefly perfused via the left ventricle with 0.7 %
heparin in 0.9 % NaCl followed by perfusion with either
(1) freshly prepared 4 % formaldehyde (FA) in 0.01 M
phosphate buffered saline (PBS, pH 7.4; female rats,
n = 4) or (2) FA fixatives at variable pH (female rats,
n = 8) as described previously (Asan 1998; Eliava et al.
2003). The brains were then dissected and post-fixed over
night at 4 C in the corresponding fixative [without glu-
taraldehyde in (2)]. Subsequently, tissue was successively
infiltrated with 10 and 20 % sucrose in PBS, frozen in
liquid nitrogen-cooled 2-methylbutane and stored at
-80 C. For sectioning, tissue was slowly thawed to 4 C
and serial 45-lm-thick coronal vibratome sections were cut
in a PBS bath at 4 C (Eliava et al. 2003).
For EM, female (n = 2) and male (n = 2) anesthetized
rats were pre-rinsed with a heparin-sodium solution, per-
fused using freshly prepared 4 % FA in 0.1 M phosphate
buffer (PB, pH 7.4) and post-fixed in the same fixative over
night at 4 C. Then, coronal sections (40 lm) were cut on a
vibratome in 0.1 M PB at room temperature and subse-
quently used for EM. Vibratome sections for EM and LM
were processed for immunohistochemistry in wells of
tissue culture plates.
For ISH, female (n = 7) and male (n = 9) anesthetized
rats were decapitated, brains were immediately dissected,
frozen in liquid nitrogen-cooled 2-methylbutane and stored
at -80 C. Serial coronal sections (10 lm) were cut on a
cryostat set at -25 C and thaw-mounted on slides. Sub-
sequently, sections were fixed in freshly prepared 4 % FA
in 0.01 M PBS, transferred to 100 % ethanol and stored at
4 C as described previously (Bonn et al. 2012). If not
mentioned otherwise, the following steps were carried out
at room temperature.
Single and double immunohistochemistry for LM
Vibratome sections were pre-incubated in 5 % normal goat
serum (NGS) diluted in 0.5 % Triton X-100 in 0.01 M PBS
for 2 h and subsequently incubated in antibody solution
consisting of PBS with 0.5 % Triton X-100 and 1 % NGS
as described by Eliava et al. (2003). Serotonergic fibers
were detected using polyclonal rabbit (rb) anti-5-HTT
(1:750, catalog #PC177L, Merck, Darmstadt, Germany) or
polyclonal rb anti-serotonin (5-HT, 1:45,000, catalog
#20080, Sorin Biomedica, Duesseldorf, Germany). Primary
antibody incubation was done for 48 h at 4 C with light
agitation. Then, sections were washed 69 10 min in PBS
and incubated over night at 4 C with biotinylated goat
anti-rb IgG (1:500, catalog #BA-1000 Vector, Wiesbaden,
Germany), followed by incubation in avidin–biotin com-
plex (ABC) for 2 h according to Eliava and co-workers
(2003). Chromogenic visualization was carried out apply-
ing the glucose oxidase-diaminobenzidine method descri-
bed by Zaborszky and Heimer (1989). This immuno-
reaction was amplified by nickel intensification (Liposits
et al. 1986). For double labeling, the sections were further
reacted with the second primary antibody (polyclonal rb
anti-NPY, 1:8000, catalog #N9528, Sigma, Munich,
Germany), biotinylated goat anti-rb IgG and ABC as
described above and the NPY signal was visualized with
non-intensified DAB (Eliava et al. 2003). After rinsing in
three changes of PBS (10 min each), sections were
mounted on glass slides, dried overnight, dehydrated in
ethanol (70, 90, 96, 29 100 %, 3 min each), cleared in
xylene (29 3 min) and coverslipped in DEPEX (Serva,
Heidelberg, Germany). Sections were analyzed with a
Zeiss axioscope (Zeiss, Oberkochen, Germany) and pho-
tographs were made using the Neurolucida system
(Microbrightfield, Magdeburg, Germany). Pictures were
adjusted for brightness and contrast in Adobe Photoshop
CS.
Double immunohistochemistry for EM
Vibratome sections were rinsed in 0.1 M Tris-saline buffer
(TS, pH 7.6, 29 10 min), incubated in TS containing 0.5 %
BSA for 30 min and briefly rinsed in TS again. Then,
sections were incubated for 46–48 h in an antibody cock-
tail of polyclonal rb anti-NPY (1:8000, see above) and
polyclonal rat anti-5-HT (1:500, catalog #MAS055,
Harlan-Sera-Lab, Belton, United Kingdom) diluted in TS
containing 0.1 % BSA. The following steps were all car-
ried out according to Waselus and co-workers (2005):
(1) incubation with biotinylated goat anti-rb secondary
antibody (1:500, catalog #BA-1000, Vector Laboratories,
Burlingame, CA) and ABC (Vector Laboratories), (2)
visualization of NPY with DAB, detection of 5-HT
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immunoreactivity by immunogold-silver localization using
goat anti-rat IgG conjugated to 1-nm gold particles (1:50,
catalog #25181, Electron Microscopy Sciences, Fort
Washington, PA, USA), (3) incubation in 2 % glutaralde-
hyde in 0.01 M PBS for 10 min, (4) silver intensification of
gold particles for 10 min using a silver enhancement kit
(Polysciences Inc., Warrington, PA), (5) incubation in 2 %
osmium tetroxide in 0.1 M PB for 1 h, (6) dehydration and
(7) flat embedding. Then, a small area containing La and
BL was cut from the flat embedded section and re-
embedded onto Epon blocks. Ultrathin sections (74 nm)
containing La or BL, were cut, placed onto grids, con-
trasted with uranyl acetate and lead citrate (Reynolds 1963)
and examined with an electron microscope (LEO AB 912,
Zeiss NTS, Oberkochen, Germany and Morgagni, Fei
Company, Hillsboro, OR). Pictures were adjusted for
brightness and contrast in Adobe Photoshop CS.
In situ hybridization
Generation of cRNA probes specific for rat NPY (GenBank
accession: NM_012614), rat 5-HT1A (GenBank accession:
NM_012585.1) and rat 5-HT2C mRNA (GenBank acces-
sion: NM_012765.3) was performed as described by Bonn
et al. (2012). A cDNA fragment of mouse 5-HT3 mRNA
(GenBank accession: NM_013561.2; 92 % homology to
the corresponding rat sequence) was cloned into pGEM-T
vector (Promega, Mannheim, Germany) and further pro-
cessed for generation of antisense and sense cRNA probes
as previously described (Bonn et al. 2012).
Procedures for hapten labeling of cRNA probes were
done as follows: for single labelings, cRNAs were reacted
using biotin-, fluorescein- or digoxigenin (DIG)-RNA
labeling mixes (all Roche, Mannheim, Germany). For
double labelings, fluorescein- and DIG-labeled cRNA
probes were used for NPY and 5-HT2C mRNA detection
as required; for 5-HT1A mRNA detection only DIG-
labeled cRNA was used. For triple labelings, NPY cRNA
was reacted using biotin-RNA labeling mix, 5-HT2C
cRNA with fluorescein-RNA labeling mix and 5-HT1A
cRNA with DIG-RNA labeling mix. Rehydration in a
graded series of ethanol, acetylation and pre-hybridization
were done according to Bonn et al. (2012). Sections were
covered with hybridization solution containing one, two or
three differently labeled cRNA probes of interest.
Hybridization to nucleic acid targets was carried out for
16–20 h at 57–58 C followed by post-hybridization
washes as described by Bonn et al. (2012). Subsequently,
tissue was treated with blocking buffer according to the
manufacturer’s instruction (Perkin Elmer, Rodgau, Ger-
many). ISH signals were detected using either of four
methodic variations: (1) for chromogenic detection (CISH),
blocked sections were incubated in alkaline phosphatase
(AP)-conjugated anti-fluorescein (1:600, Roche) or anti-
DIG Fab fragments (1:600, Roche) for 2.5 h, rinsed and
subjected to chromogenic detection with nitro blue tetra-
zolium (NBT)/5-bromo-4-chloro-30-indolyphosphate
(BCIP; Roche) for 16–20 h. Development of the enzyme
reaction was carried out in the dark and chromogenic signal
intensity was controlled by brief microscopic observation
at regular intervals. (2) For highly sensitive tyramide signal
amplified fluorescence ISH (HS-TSA-FISH), sections were
incubated in horseradish peroxidase (POD)-conjugated
anti-DIG or anti-fluorescein Fab fragments (1:1000,
Roche) for 2.5 h, reacted with TSATM Biotin (Perkin
Elmer) and further incubated in the dark with AlexaFluor
488-conjugated streptavidin (Invitrogen, Darmstadt, Ger-
many). (3) For moderately sensitive TSA fluorescence ISH
(MS-TSA-FISH), tissue incubated with POD-conjugated
Fab fragments as described above was reacted with TSATM
Cy3 (Perkin Elmer). (4) For low sensitive TSA fluores-
cence ISH (LS-TSA-FISH), sections reacted with a biotin-
labeled cRNA probe were incubated with POD-conjugated
streptavidin (Perkin Elmer) rinsed and reacted with TSATM
Cy3 (for further details see Bonn et al. 2012).
Chromogenic detection-reacted sections were mounted
in Aquatex (Merck), in FISH-reacted sections nuclei were
stained using 300 nM DAPI (Roche) and sections were
mounted with Fluoro-Gel (Science Services, Munich,
Germany). With single CISH, clear and specific signals
were produced for each cRNA probe. Equivalent reaction
intensity was found for NPY and 5-HT2C mRNA single
detection using HS-TSA-FISH and for NPY also using MS-
TSA-FISH. NPY mRNA detection using LS-TSA-FISH
labeled cells less intensely and was therefore not used for
quantitative analyses (not shown; cf Bonn et al. 2012). For
NPY/5-HT2C double FISH, first HS-TSA-FISH was
applied to detect 5-HT2C mRNA. Reacted sections were
then subjected to a POD block in 0.02 N HCl, rinsed and
then MS-TSA-FISH was applied to detect NPY mRNA.
For detection of NPY with 5-HT1A and with 5-HT3
mRNA, respectively, a combination of FISH and CISH
previously described by Bonn et al. (2012) was applied: the
fluorescein-labeled NPY cRNA was first detected using
HS-TSA-FISH followed by CISH detection of DIG-labeled
receptor cRNA probes, DAPI-staining and mounting. For
triple labelings (NPY, 5-HT1A and 5-HT2C mRNA), we
applied double FISH using HS-TSA-FISH for 5-HT2C and
LS-TSA-FISH for NPY mRNA detection, respectively,
followed by CISH for 5-HT1A mRNA detection, DAPI-
staining and mounting. Sections were observed with a
Zeiss axioscope (see above) equipped with appropriate
fluorescence and bright field filter systems and analyzed
using a digital Spot camera (Visitron Systems, Puchheim,
Germany) and the Spot Advanced software (Diagnostic
Instruments, Inc., Sterling Heights, MI, USA). Pictures
424 Brain Struct Funct (2013) 218:421–435
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were adjusted for brightness and contrast, merged and
assembled in Spot Advanced and Adobe Photoshop CS.
Analysis and controls
On the LM level, La and BL were identified according to
the rat brain atlas by Paxinos and Watson (2007) at low
magnification, all NPY-ir neurons were localized and
counted and the number of apparent serotonergic contacts
was determined. Each 5-HTT-ir fiber apparently contacting
an NPY-ir soma (no visible gaps between fiber and NPY-ir
soma at different focus levels at 1009 magnification with
immersion oil) was considered as one apposition. For each
animal, we analyzed four to eight vibratome sections
containing La and BL at anterior, medial and posterior
coronal section level. For controls, we omitted the primary
antibodies from the first, second or from both reaction
sequences.
To ensure that both immunolabels were clearly detect-
able in ultrathin sections used for EM investigations, only
tissue sections collected near the tissue-Epon interface,
where penetration of the antibodies was optimal, were
included in the analyses. NPY-ir structures were identified
due to intense DAB labeling. Synaptic axon terminals were
only counted as 5-HT-ir if at least two immunogold-silver
particles were present and if the same structure displayed
labeling in several serial sections. To ensure specificity of
the immunogold-silver signal, the surrounding neuropil
was analyzed and it was established that no unspecific
labeling, e.g. in myelin sheath, was present. When primary
antibodies were omitted in controls, labeling was lacking in
both DAB and immunogold silver-stained sections.
In ISH control labelings, substitution of antisense cRNA
probes by an equivalent amount of hapten-labeled sense
cRNA probe, omission of cRNA probes and cross controls
(mix of one antisense cRNA probe of interest with another
sense cRNA probe and detection using the double or triple
detection protocols) lacked unspecific staining. These
results indicate that the antisense cRNA probes were spe-
cific and the detection systems did not create labeling
artifacts.
For quantitative analyses of co-expression of NPY and
5-HTR mRNA in double ISH labelings, tissue sections
spaced at least 30 lm apart were analyzed to rule out
repeated evaluation of the same neuron. Per animal, at least
nine cryosections from anterior, medial and posterior
coronal section level of left and right La and BL and at
least 35 neurons per nucleus were analyzed. Then, the
percentage values per animal were subjected to statistical
tests. To test the normal distribution of double ISH data we
used the Shapiro–Wilk test and to analyze statistical dif-
ferences in sex and nuclei, we applied a two-way ANOVA.
Statistical analyses were carried out using the free software
environment for statistical computing R, version 2.10.0
(http://cran.r-project.org/). For triple labelings, only quali-
tative evaluation was done.
Results
NPY, 5-HTT and 5-HT immunoreactivity:
LM observations
Using single labeling, NPY-immunoreactivity in the Ce
was scarce, but numerous fusiform or round NPY-ir somata
(Fig. 1a, insets) and dense plexus of NPY-ir fibers were
observed in the La and BL (Fig. 1a). Similarly, in 5-HTT
Fig. 1 Light micrographs of NPY (a) and 5-HTT-immunoreactiv-
ities (b) in frontal sections through the rat amygdala at a mid-
rostrocaudal level. BL basolateral nucleus, Ce central nucleus, La
lateral nucleus. Insets in a show a fusiform (1) and a round (2) NPY-ir
soma, inset in b shows a high magnification of narrow 5-HTT-ir
afferents with irregularly spaced oblong varicosities in La. Scale bars
460 lm in a and b, 20 lm in all insets
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single labeling studies, 5-HTT-ir fiber density in Ce was
low (Fig. 1b) but the La and BL subregions exhibited a
very dense plexus of narrow, smooth 5-HTT-ir axons with
irregularly spaced oblong varicosities (Fig. 1b, inset).
5-HT labeling yielded comparable innervation patterns and
fiber morphology, indicating that immunoreactivity for
5-HTT reliably labeled serotonergic fibers of this type (data
not shown). Immunolabeling for 5-HT was generally less
intense and somewhat more variable as compared to
immunodetection of 5-HTT. In addition, a few axons
characterized by a larger diameter and greater varicosity
size were detected using immunolabeling for 5-HT (not
shown). Fibers of this type were generally rare in the
amygdala, were absent in La and very scarce in BL, and
were never found in close vicinity to NPY-ir somata in BL.
Based on the LM analysis of morphological interrelations
of serotonergic afferents and NPY-ir somata, quantitative
analyses were carried out using dual labeling of NPY and
5-HTT, which yielded specific and consistent results of
numerous contacts between serotonergic fibers and NPY-ir
neurons (Fig. 2). In La, 98.4 % (SD: ±2.6; Nanimals = 6;
nneurons = 177) of all NPY-ir neurons displayed peri-
somatic appositions of 5-HTT-ir fibers, and 2.1 (SD: ±0.3)
appositions per soma were counted, on average. In BL,
95.3 % (SD: ±6.5; Nanimals = 6; nneurons = 102) of all
NPY-ir neurons displayed peri-somatic appositions of
5-HTT-ir fibers, and 2.4 (SD: ±0.5) appositions per soma
were counted, on average (Fig. 2a, b). 5-HTT-ir fibers
running close to the NPY-ir somata for some distance were
frequently observed in both nuclei (Fig. 2c). Moreover,
appositions of 5-HTT-ir fibers on proximal NPY-ir pro-
cesses were often found (Fig. 2a, c). Due to the difficulty in
consistently identifying NPY-labeling in proximal pro-
cesses caused by the partially weak reaction product in
dual-labeled tissue, quantitative analysis of contacts onto
dendrites was not carried out. Separate evaluation of
appositions on fusiform and round NPY-ir somata yielded
no differences.
NPY and 5-HT immunoreactivity: EM observations
Since use of two primary antibodies raised in the same
species (rb) was not suitable for the EM dual labeling
procedure, a rat anti-5-HT antibody was utilized instead of
rb anti-5-HTT for this portion of the study. At the ultra-
structural level, NPY-immunoreactivity was specifically
detected by chromogenic visualization of DAB within the
cytoplasm of fusiform and round cell bodies. These pos-
sessed irregularly formed and frequently indented nuclei
(Figs. 3, 4). The immunoperoxidase reaction product was
also found within proximal dendrites (Fig. 3a, b) that
received synaptic contacts from unlabeled axon terminals
(uT; Fig. 3b). Moreover, axon terminals containing NPY
frequently formed symmetric synapses with unlabeled
dendrites (uD; Fig. 3c) and unlabeled somata (data not
shown). Asymmetric contacts were not observed between
NPY-ir axon terminals and postsynaptic structures. In
general, NPY-ir axon terminals were densely packed with
synaptic vesicles and exhibited diffusely distributed DAB
reaction product. In mitochondria, no DAB reaction prod-
uct was observed (Fig. 3c). 5-HT-ir terminals exhibited
densely packed, small round vesicles and formed mostly
symmetric-type synaptic contacts with target structures
(Fig. 4b, c, e). The EM approach confirmed the LM anal-
ysis of dual immunoreactions. Using serial section analysis,
direct membrane appositions of 5-HT-ir axons on round
and fusiform NPY-ir cell bodies and small symmetric-type
synaptic contacts were observed, in one case on a small
somatic spine (Fig. 4a–e).
5-HTR mRNA expression of NPY mRNA-reactive
neurons
For all mRNAs, single CISH showed a labeling pattern
similar to that seen in previous ISH studies (Bonn et al.
2012; Mengod et al. 1990; Miquel et al. 1991; Tecott et al.
Fig. 2 NPY-ir neurons (brown) displaying close appositions of
5-HTT-ir fibers (black) in BL. Arrows and arrowheads (a–c) point
to 5-HTT-ir apparent contacts on NPY-ir somata and proximal
processes, respectively. Scale bar in a is 20 lm and is also valid for
b and c
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1993). Cells displaying varying levels of reactivity for
NPY mRNA were scattered throughout La and BL (Figs. 5,
6, 7, 8). Many lightly and few moderately 5-HT1A mRNA-
reactive cells were found in both nuclei (Figs. 5, 8).
5-HT2C mRNA-reactive cells were numerous with com-
paratively intense reactivity in La (Fig. 6b) and were also
frequently found but with lower reaction intensity in BL
(Fig. 6e). Moderate 5-HT3 mRNA-reactivity was observed
in scattered cells in both nuclei (Fig. 7). Quantitative
analyses of double ISH for NPY and 5-HTR mRNAs
showed that in La and BL of female rats, 58.2 and 58.1 %,
respectively, of NPY mRNA-reactive neurons co-expres-
sed 5-HT1A mRNA, in male rats the percentage was 53.9
and 54.2 %, respectively (Figs. 5, 9). In La and BL of
females, 33.0 and 35.6 %, respectively, of NPY mRNA-
reactive neurons co-expressed 5-HT2C mRNA; in males it
was 42.1 and 29.6 %, respectively (Figs. 6, 9). Inter-indi-
vidual differences in percentages as represented by the
standard deviations of arithmetic means were much higher
for NPY/5-HT2C than for NPY/5-HT1A co-expression for
both sexes in both nuclei, particularly in the BL of females
(Fig. 9). The results of corresponding two-way ANOVA
showed no significant differences for co-expression of the
respective 5-HTR in NPY-producing neurons between
nuclei or gender. No co-expression of NPY and 5-HT3
mRNA was observed in La and BL of rats of both sexes
(Fig. 7). In FISH/CISH triple labelings, co-expression of
NPY with 5-HT1A and 5-HT2C mRNA was detected in
Fig. 3 NPY-immunoreactive
profiles in the La at the
ultrastructural level. NPY-
immunoreactivity is localized in
cell bodies frequently
displaying indented nuclei
(arrow in a), in dendrites
(b) synaptically contacted by
unlabeled terminals (inset
represents magnification of
boxed area in b; arrow points at
synaptic cleft) and in axon
terminals forming symmetric
synapses (c arrows point at
postsynaptic area in a small
unlabeled dendrite).
M mitochondrion, uD unlabeled
dendrite, uT unlabeled terminal.
Scale bar in a is 5,000 nm,
in b and c 500 nm
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individual cells in La and BL (Fig. 8). In addition, double-
labeled neurons co-expressing NPY and 5-HT2C mRNA
(Fig. 8) or NPY and 5-HT1A (not shown), and neurons
single labeled for 5-HT1A or 5-HT2C mRNA (Fig. 8) and
for NPY mRNA (not shown) were observed in the triple
labeled preparations.
Discussion
The LM analyses of the present study suggest that virtually
all NPY-ir neurons in La and BL receive peri-somatic
serotonergic innervation. Direct membrane appositions and
small symmetric-type synaptic contacts between seroto-
nergic afferents and NPY-ir neurons were verified by
ultrastructural analysis. The intense peri-somatic seroto-
nergic innervation indicates a substantial direct impact of
serotonergic innervation on NPY neurons, since neuro-
transmission at the soma is in a position to prominently
influence neuronal function. Our multiple ISH analyses
show that NPY mRNA-reactive neurons in the La and BL
differentially express 5-HT1A and/or 5-HT2C mRNA
indicating diverse effects of 5-HT on this interneuronal
subpopulation. 5-HT3 mRNA expression was not observed
in NPY-producing neurons.
Methodological considerations
5-HTT has frequently been used as a reliable and specific
marker for serotonergic afferents in different brain regions
(Brown and Molliver 2000; Eliava et al. 2003; Parent et al.
2010). Accordingly, our immunolabeling of serial sections
using 5-HT and 5-HTT antibodies showed similar patterns
of innervation in La and BL, with virtually identical
characteristics of innervation density and fiber morphology
corresponding to earlier findings (e.g. Fallon and Ciofi
1992; Muller et al. 2007b; Vertes et al. 1999). Both reac-
tions labeled dense plexus of narrow serotonergic fibers in
Fig. 4 Interrelations between
5-HT-ir axon terminals and
NPY-ir somata in La and BL.
a A fusiform NPY-ir soma
displaying a direct membrane
apposition with a 5-HT-ir axon
terminal. b, c Serial sections of
boxed area in a at higher
magnification. Small boxes
frame immunogold-silver
particles located within the
5-HT-ir axon terminal;
arrowhead indicates the
membrane contact. d A round
NPY-ir soma whose somatic
spine receives a symmetric-type
synaptic contact from a 5-HT-ir
axon terminal (boxed area)
shown at higher magnification
in e. Small boxes in e frame
immunogold-silver particles
located within the 5-HT-ir axon
terminal and arrowhead
indicates the synaptic contact.
Scale bars in a and d are
5,000 nm, in c 1,000 nm (also
valid for b) and in e 1,000 nm
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La and BL presumably originating in the DR (Brown and
Molliver 2000; Kosofsky and Molliver 1987; Mamounas
et al. 1991). Thicker beaded fibers representing serotoner-
gic afferents from the median raphe (Kosofsky and Mol-
liver 1987), which supposedly lack 5-HTT (Brown and
Molliver 2000), were detected in 5-HT-immunolabeling
only, were not observed in the La and only very rarely
found in the BL, in accordance with findings for median
raphe afferents to the amygdala (Vertes et al. 1999).
Patterns of NPY-immunoreactivity and morphology of
NPY-ir neurons in La and BL were consistent with the
existing literature (Gustafson et al. 1986; Quidt de and
Emson 1986). In dual labeling studies, NPY-immunolabel-
ing provided detection of neuronal somata but did not always
reliably label dendrites. Therefore, quantitative analyses
were restricted to peri-somatic contacts between serotoner-
gic afferents and NPY-ir neurons. 5-HT/NPY double
immunoelectron microscopic preparations served to prove
Fig. 5 Double ISH (FISH/CISH) for NPY and 5-HT1A mRNA in La
(a–c) and BL (d–f). Arrows indicate co-expression of both mRNAs in
(a–c). Arrowheads in (a–c) point to cells single labeled for NPY and
5-HT1A mRNA, respectively. Scale bar in c (50 lm) is also valid for
a and b, scale bar in f (50 lm) is also valid for d and e
Fig. 6 Double ISH (double FISH) for NPY and 5-HT2C mRNA in
La (a–c) and BL (d–f). Arrows and inset in c and f indicate co-
expression of both mRNAs. Arrowheads in d–f point to single-labeled
NPY mRNA-reactive cells. Scale bar in c (50 lm) is also valid for
a and b, scale bar in f (50 lm) is also valid for d and e
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direct membrane contacts and synapses between serotoner-
gic afferents and NPY-ir somata. 5-HT- and NPY-immuno-
reactivity was localized using a combined pre-embedding
immunoperoxidase and immunogold detection method. This
technique provides high resolution subcellular localization
of the antigens while preserving ultrastructural morphology.
However, pre-embedding immunolabeling in vibratome
sections can produce limited reagent penetration, a caveat
with this approach. In order to minimize the problems asso-
ciated with poor penetration, we collected ultrathin sections
near the tissue-Epon interface where penetration of the
antibody is optimal to ensure that both immunolabels were
clearly detectable in sections included in the analysis.
Serotonergic innervation of NPY-ir interneurons:
morphological characteristics and functional
implications
Our analyses indicated that NPY neurons in La and BL
possessed either round or fusiform cell bodies. NPY-ir La
Fig. 7 Double ISH (FISH/CISH) for NPY and 5-HT3 mRNA in BL.
No co-expression of NPY and 5-HT3 mRNA was observed. Large
arrows point to single-labeled NPY mRNA-reactive neurons, small
arrows to single-labeled 5-HT3 mRNA-reactive neurons. Scale bar in
c (50 lm) is also valid for a and b
Fig. 8 Triple ISH for NPY, 5-HT1A and 5-HT2C mRNA in BL. Co-
expression of NPY with 5-HT1A and 5-HT2C was found in
individual neurons (large arrows, inset in d). Small arrows point to
a neuron double labeled for NPY and 5-HT2C mRNA, arrowheads
indicate single-labeled cells for 5-HT1A and 5-HT2C mRNA. Scale
bar in d (50 lm) is also valid for a–c
Fig. 9 Co-expression of NPY mRNA with 5-HT1A and 5-HT2C
mRNA. Data are presented as arithmetic mean ? standard deviation.
The numbers above the bars indicate percentage values of co-
expression. BL basolateral nucleus, La lateral nucleus
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and BL neurons represent a subpopulation of somatostat-
inergic neurons, for which an ovoid to fusiform perikaryal
morphology was described (McDonald 1989). Recent cell
classification according to multifunctional parameters
using cluster analyses additionally documented that La
NPY-ir neurons belong to electrophysiologically and
morphologically distinct subclasses of interneurons
(Sosulina et al. 2006). Our LM data show that virtually all
fusiform and round NPY-ir somata in the La and BL are
contacted by serotonergic fibers with the morphology
proposed for DR afferents, and most somata were targeted
by more than one serotonergic fiber. The ultrastructural
data provide compelling evidence that this important
interneuron subgroup is a direct target of serotonergic
innervation.
Previous quantitative ultrastructural studies have docu-
mented that 89 % of SOM-ir terminals innervating pyra-
midal cells contact distal dendrites and spines, and that
about 15 % of all terminals synapsed with other interneu-
rons (Muller et al. 2007a). Since virtually all NPY-ir
interneurons are also somatostatinergic with about 30 %
(BL) and 80 % (La) of SOM-ir neurons co-expressing NPY
(McDonald 1989), it is likely that distal pyramidal cell
dendrites are preferential targets also of NPY-ir terminals.
Previous documentation of presumably symmetric synaptic
contacts of NPY-ir terminals on BL pyramidal cell den-
dritic structures (Cui et al. 2008), and our findings of
exclusively symmetric synaptic contacts of NPY-ir termi-
nals and of small dendrites as postsynaptic targets support
this suggestion. Recent electrophysiological and behavioral
data provide compelling support for an inhibitory effect of
NPY on pyramidal cells in the basolateral amygdala,
mediated via Y1 NPY receptors (Giesbrecht et al. 2010;
Sosulina et al. 2008; Thorsell 2010). Thus, NPY-producing
interneurons may be in a position to inhibit the propagation
of excitatory inputs onto spines and distal dendrites to the
pyramidal cell body. On the other hand, NPY-ir neurons
might also target inhibitory interneurons, as has been
documented for other subgroups of interneurons (Muller
et al. 2005, 2007a). Quantitative ultrastructural analyses,
which will be required to conclusively document the exact
synaptology of NPY-ir La and BL interneurons, are com-
plicated by the fact that NPY-immunoreactivity may be
present in extrinsic afferents (e.g. Cui et al. 2008; Truitt
et al. 2009), albeit in some of these at a very low level
(Asan 1998; Gustafson et al. 1986). In any case, the anx-
iolytic effect of NPY in the amygdala is linked to the
function of NPY-ir interneurons, since the number of these
neurons is correlated closely with anxiety-like behavior
(Truitt et al. 2009; Yilmazer-Hanke et al. 2002, 2004).
Serotonergic afferents to the basolateral amygdaloid
complex originate mostly in the dorsal part of the mid-
rostrocaudal region of the DR (Lowry et al. 2005). This DR
region is activated by different stress paradigms and anx-
iety-related stimuli, including anxiogenic drugs (Abrams
et al. 2005; Amat et al. 1998; Gardner et al. 2005; Grahn
et al. 1999). Accordingly, behavioral studies using micro-
dialysis to assess 5-HT concentrations in the BL showed an
increase in 5-HT release during stress and anxiety states
(Kawahara et al. 1993; Rueter and Jacobs 1996; Zanoveli
et al. 2009). Our morphological findings indicate that these
stress- and anxiety-responsive serotonergic afferents may
be in a position to influence the activity of NPY-ir inter-
neurons and thus may modulate an important intrinsic
anxiolytic inhibitory network of the La and BL.
Serotonin receptor expression of NPY-producing
neurons
To date, 5-HTR expression of NPY-producing amygdaloid
interneurons has not been studied. Our findings document
that more than half of NPY mRNA-reactive interneurons in
the La and BL co-express 5-HT1A and between 30 and
40 % co-express 5-HT2C mRNA. 5-HT1A- and 5-HT2C-
expressing NPY-producing neurons apparently represent
largely separate populations with individual neurons co-
expressing both receptors and a few cells not expressing
either. Whether the 5-HT1A- and 5-HT2C-expressing
neurons represent the two morphological subclasses of
NPY neurons with round or fusiform cell bodies, or per-
haps differ with respect to their postsynaptic targets,
remains to be determined. Furthermore, while the present
results document that NPY mRNA-reactive neurons are
capable of producing the respective receptors, the respon-
sivity of the neurons to serotonergic input depends on
further parameters, such as mRNA editing of 5-HT2C
(Werry et al. 2008), the actual level of receptor proteins,
the subcellular localization, membrane insertion and
desensitization processes, and expression of possible
additional 5-HTR (see also below). For 5-HT3, we docu-
mented that this receptor is not expressed in NPY-
producing neurons, a finding consistent with earlier
observations that 5-HT3-ir neurons do not overlap with
somatostatinergic neurons in the La and BL (Mascagni and
McDonald 2007).
The proportions of NPY mRNA-reactive neurons
expressing 5-HT1A and 5-HT2C did not differ between La
and BL, indicating that serotonergic influence is similar in
both nuclei. Moreover, sex differences were lacking in both
nuclei. However, the inter-individual variations were large
between animals for NPY/5-HT2C mRNA co-expression,
particularly in the BL of female animals. This might
indicate that 5-HT2C expression is subject to extrinsic
influence—a possible mechanism for modulation of the
5-HT responsiveness of NPY-producing neurons, for
instance by gonadal or adrenocortical stress hormones.
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In female rats, 5-HTR levels in the amygdala and other
brain regions are regulated by estradiol (Biegon and
McEwen 1981). Sex differences in 5-HT transmission
parameters and anxiety-like behavior are frequent (e.g.
Duchesne et al. 2009; Mitsushima et al. 2006), and can
easily be addressed in future experimental studies.
Serotonin innervation and receptor expression
of identified La and BL neurons: implications
for anxiety and stress
The excitability of pyramidal cells in the La and BL, which
presumably represents a functional basis of anxiety states,
is potently controlled by inhibitory GABAergic interneu-
rons (Lang and Pare 1997, 1998; Rainnie et al. 1991;
Washburn and Moises 1992). Serotonergic modulation of
intrinsic inhibitory circuits in these nuclei, therefore,
appears of particular importance for adequate emotionality,
and dysfunction of inhibitory control might underlie clin-
ically relevant behavioral alterations associated with stress
and anxiety disorders. The dense serotonergic fiber plexus
of the La and BL have been shown to form numerous
contacts with pyramidal cells and different types of inter-
neurons (Muller et al. 2007b). Morphological characteris-
tics of contacts on other interneurons were similar to those
documented for serotonergic innervation of NPY-ir neu-
rons in the present study. Thus, our findings complement
the previous findings, indicating serotonergic input to
diverse interneuronal subpopulations in these nuclei,
including the small but functionally important population
of NPY-ir interneurons.
Numerous pharmacobehavioral studies in rodents have
indicated that serotonergic transmission via the 5-HT1A, 2
and 3 receptor subtypes in the basolateral amygdala is of
crucial importance for serotonergic impact on anxiety-like
behavior, particularly following exposure to different stress
or fear conditioning paradigms (Campbell and Merchant
2003; Christianson et al. 2010; Gonzalez et al. 1999; Li
et al. 2012; Menard and Treit 1999; Morrison and Cooper
2012; Nevins and Anthony 1994). 5-HT1A and 5-HT2 are
G protein-coupled receptors, but while 5-HT1A activation
mediates inhibitory membrane hyperpolarization by open-
ing G protein-coupled inwardly rectifying potassium
channels (Reuveny et al. 1994), 5-HT2 activation increases
the firing rate of neurons (Barnes and Sharp 1999; Rainnie
1999), with 5-HT2C presumably facilitating excitatory
membrane depolarization by closing two-pore domain
potassium channels, especially TASK-3 (Weber et al.
2008). 5-HT3 is the only ionotropic 5-HTR, a cation-
selective ion channel (Barnes and Sharp 1999). While
5-HT3 activation in the amygdala appears to exert mostly
anxiogenic effects (Mascagni and McDonald 2007), evi-
dence for both anxiogenic and anxiolytic effects of
modulating 5-HT1A and 5-HT2 receptor activation has
been given (Menard and Treit 1999). The majority of
recent findings points to primarily anxiolytic actions of
5-HT1A and anxiogenic actions of 5-HT2C (Christianson
et al. 2010; Leite-Panissi et al. 2006; Li et al. 2012;
Morrison and Cooper 2012; Vicente and Zangrossi 2011).
In our ISH studies, we found 5-HT1A and 5-HT2C
mRNA in numerous cells of the La and BL in addition to
NPY-producing cells. 5-HT1A and 5-HT2A have been
localized to both pyramidal cells and PV-producing
inhibitory interneurons in the BL (Aznar et al. 2003;
McDonald and Mascagni 2007). It has not been studied yet
whether the different receptors are localized in the same
cells or in separate subgroups. 5-HT2A was detected
additionally in a subpopulation of SOM-ir interneurons
(McDonald and Mascagni 2007), but whether this sub-
population overlaps with that of NPY-producing somato-
statinergic interneurons has not been determined. The
identity of the strongly and moderately 5-HT2C mRNA-
reactive NPY mRNA-negative cells observed in our ISH
investigation in the La and BL, respectively, is unclear,
since the cellular expression of 5-HT2C in the amygdala
has not been studied yet. However, the high frequency of
these cells in the La makes a production of this receptor in
pyramidal cells likely.
In view of the expression of inhibitory and excitatory
5-HTR in both pyramidal cells and inhibitory interneurons,
interpretation of the pharmacobehavioral findings is not
trivial. Rodriguez-Manzanares and co-workers (2005)
showed that stress, which is accompanied by elevated 5-HT
concentration in the basolateral amygdala (Amat et al.
1998; Rueter and Jacobs 1996), dampens the inhibitory
control of GABAergic interneurons facilitating pyramidal
cell activation and the formation of fear memory. 5-HT1A-
mediated serotonergic inhibition of strongly inhibitory
NPY neurons which target pyramidal cells might well be
an element of this process. On the other hand, continuous
suppression of GABAergic inhibitory control would lead to
hyperexcitation of the basolateral amygdala, a state often
considered as a correlate of increased, mostly negative,
emotional state as indicated by increased anxiety or anxi-
ety-like behavior in animals (Isoardi et al. 2007; Rosen and
Schulkin 1998; Rosenkranz et al. 2010; Zhou et al. 2010).
Based on various experimental evidence, it has been sug-
gested that 5-HT2A receptor activation in PV-producing
interneurons enhances inhibition of pyramidal cells,
resulting in a reduction of output to circuits mediating
anxiety-related behavior (Hale et al. 2010; Rainnie 1999).
Serotonergic excitation of the subgroup of 5-HT2C-
expressing NPY neurons might contribute to enhanced
pyramidal cell inhibition. The proposed functions of 5-HT/
NPY interaction via the different receptors require a tem-
poral sequence of 5-HT-mediated effects, perhaps caused
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by desensitization mechanisms or other differential mod-
ulation of receptor functions (Snoeren et al. 2011), which
might also provide the basis for functions of NPY-
producing neurons expressing both 5-HTR subtypes.
However, the suggestion of a net inhibitory effect of
5-HT2C-mediated excitation of NPY-producing interneu-
rons is difficult to reconcile with the predominantly
anxiogenic properties of 5-HT2C agonists in the BL
(Christianson et al. 2010; Li et al. 2012). Further mor-
phological and electrophysiological experiments are
required to test the different hypotheses.
In conclusion, our findings suggest that 5-HT/NPY
interactions contribute to the complicated network of
intrinsic inhibitory circuits in the basolateral amygdala, a
nodal structure for modulating anxiety-related behavior,
emotional learning and memory formation (Lowry et al.
2005; Roozendaal et al. 2009). Evidence in support of dif-
ferential receptor expression in the small but functionally
important inhibitory NPY-producing interneuron population
suggests diverse actions of 5-HT, supporting the relevance of
serotonergic transmission in the La and BL for adjusting
behavior and cognitive functions to changing environmental
demands.
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